Semax Nasal Spray Research Peptide: The ACTH Analog Cognitive Researchers Rely On

Semax is one of the most studied synthetic neuropeptides in cognitive and neurological research. Developed in Russia from the ACTH(4-7) hormone fragment, it was specifically engineered to cross the blood-brain barrier more efficiently than its parent compound, work without the hormonal side effects of ACTH itself, and remain stable long enough to produce measurable effects in research models. It is administered intranasally in research protocols, which is why researchers searching for semax nasal spray are looking for exactly what this product delivers once reconstituted.

Pure Peptide Factory stocks research-grade Semax in 5mg and 10mg vials with batch-specific HPLC verification and domestic cold-chain shipping. If your cognitive or neuroprotection research program needs a reliable domestic source, this is it.

Why Researchers Buy Semax from Pure Peptide Factory

Purity That Holds Up Under Third-Party Testing

Semax is a seven-amino-acid peptide. At that length, degradation and mislabeling are real risks from suppliers who cut corners on quality control. Every batch we ship comes with a lot-specific HPLC chromatogram and mass spectrometry report confirming the molecular weight at 854.99 g/mol and the sequence integrity of Met-Glu-His-Phe-Pro-Gly-Pro. Download the COA for your specific lot before ordering. Compare it against published values. That is the standard your research deserves.

Domestic Shipping Built for Peptide Stability

We ship from domestic cold-storage with phase-change cooling. Most orders arrive within 1 to 3 business days. Semax is sensitive to temperature excursions, and the overseas suppliers that dominate this category cannot guarantee cold-chain integrity across customs and international freight. We can.

Two Vial Sizes for Any Protocol

The 5mg vial suits pilot studies, dose-finding work, and short-term animal protocols. The 10mg vial is built for extended studies and researchers running multiple cohorts. Both ship from the same batch for consistent compound quality across your entire study.

Research Stack Available

We stock Semax alongside Selank, the complementary neuropeptide that researchers frequently study in combination. Both are stored under identical conditions. Researchers comparing or stacking Semax and Selank can source both from one supplier with batch-matched documentation.

What Is Semax?

An Engineered Improvement on a Natural Hormone Fragment

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is derived from ACTH(4-7), a fragment of adrenocorticotropic hormone, with a Pro-Gly-Pro sequence added at the C-terminal end. That addition is not cosmetic. It serves two functions.

First, Pro-Gly-Pro increases lipophilicity, which improves passive diffusion across the blood-brain barrier and may facilitate receptor-mediated transcytosis at the BBB. Second, the structural modification makes Semax significantly more resistant to enzymatic degradation than the native ACTH fragment. Natural ACTH fragments break down rapidly in gastrointestinal and cerebrospinal fluids. Semax was specifically engineered to survive long enough to reach its targets and produce measurable effects.

Unlike ACTH itself, Semax does not trigger the hormonal cascade characteristic of the parent compound. It exerts specific neurological effects without the adrenal stimulation or cortisol responses that ACTH produces, making it cleaner for research protocols where hormonal confounders must be controlled.

Molecular Profile:

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
• Molecular Formula: C39H54N10O10S
• Molecular Weight: 854.99 g/mol
• CAS: 80714-61-0
• Also known as: ACTH(4-7)PGP, HY-P1146

How Semax Works at the Neurochemical Level

Semax operates through several converging mechanisms that explain its broad utility across cognitive, anxiety, and neuroprotection research.

It inhibits enkephalin-degrading enzymes in human serum, increasing enkephalin availability. Enkephalins are endogenous opioid neurotransmitters involved in pain perception, stress response, and mood regulation. Elevated enkephalin levels interact with dopamine and serotonin systems through interconnected signaling pathways, influencing receptor activity, neurotransmitter release, and signal transduction simultaneously.

Semax also upregulates BDNF (brain-derived neurotrophic factor) secretion and increases dopamine release in key brain regions. BDNF is one of the most important growth factors for neuronal survival, synaptic plasticity, and learning. Its elevation underpins much of Semax’s cognitive enhancement and neuroprotective research profile.

At the gene expression level, Semax alters expression of genes related to immune function, chemokines, and immunoglobulins, particularly in the context of vascular system regulation. This genomic effect is relevant for ischemia and stroke research programs where neuroinflammatory gene expression is a primary endpoint.

Semax Peptide Benefits: Research Applications

Cognitive Enhancement and Nootropic Research

The nootropic research profile of Semax has more published depth than almost any other peptide in this class. Studies in rodent models showed that Semax exposure elevated serotonin metabolite 5-HIAA levels by 25% within 2 hours and up to 180% within 4 hours of administration. This elevation in serotonin metabolism suggests enhanced serotonergic activity, with downstream effects on mood, cognition, and central nervous system function.

A small-scale clinical trial monitored brain activity in research models given Semax under high-stress conditions over 24 hours. Compared to pre-trial baselines, models showed increased memory recall and extended focus intervals. The BDNF upregulation Semax produces is mechanistically consistent with these findings, as BDNF is directly involved in hippocampal synaptic strengthening that underlies learning and memory formation.

Researchers studying cognitive enhancement, attention, and learning use Semax to examine:

• BDNF expression changes in hippocampal and cortical tissue
• Serotonin and dopamine system modulation under stress conditions
• Enkephalinase inhibition and its downstream neurotransmitter effects
• Comparison with other nootropic peptides across cognitive endpoints

Anxiety and Stress Response Research

Semax has demonstrated anxiolytic effects in multiple animal models, making it relevant for researchers studying anxiety disorders, stress response systems, and neurotransmitter-based behavioral modulation.

In neonatal rat models exposed to SSRIs during the first 14 days of life, anxiety-like behavior, impaired stress responses, and disrupted learning emerged. When Semax was introduced from days 15 to 28, the anxiety-like behaviors were mitigated and learning ability improved. Researchers attributed this to Semax restoring monoamine levels disrupted by early SSRI exposure, rebalancing serotonin, dopamine, and norepinephrine signaling in ways that stabilized the excitatory-inhibitory balance in neural circuits. Notably, these behavioral improvements persisted from adolescence through young adulthood, suggesting lasting circuit-level effects rather than transient neurotransmitter changes.

Separate studies in adolescent rats subjected to maternal deprivation during the first 14 postnatal days showed increased anxiety and heightened emotional reactivity. Semax administration during days 15 to 28 restored anxiety levels to control ranges, again pointing to monoaminergic stabilization as the likely mechanism.

Researchers investigating anxiety models, early-life stress, and SSRI-related neurochemical disruption incorporate Semax to study how peptide-based interventions interact with monoamine systems.

Neuroprotection and Stroke Research

Semax has been investigated in clinical research for ischemic stroke. A clinical trial conducted on 100 ischemic stroke models showed that Semax-exposed subjects demonstrated improved rates of neurological function restoration compared to controls, with results analyzed via EEG mapping. The mechanism involves gene expression changes in immune and vascular pathways, specifically alterations in chemokine and immunoglobulin encoding that affect vascular regulation in ischemic brain tissue.

Genome-wide transcriptional analysis in rat focal ischemia confirmed that Semax affects expression of genes related to both the immune system and vascular regulation, providing a molecular basis for the observed neuroprotective effects.

Cardiovascular and Vascular Research

In experimental myocardial infarction models, Semax administration for 6 days following MI produced measurable cardioprotective effects. Control animals developed cardiac hypertrophy and decreased arterial blood pressure by day 28. Semax-exposed models showed prevention of diastolic pressure elevation in the left ventricle, reduced cardiomyocyte hypertrophy, and preserved balance between contractile and mitochondrial apparatus growth. Researchers studying post-infarction cardiac remodeling and vascular peptide effects use these findings as the basis for Semax cardiovascular protocols.

ADHD and Attention Research

Semax has been proposed as a research tool for studying ADHD-related mechanisms based on its dopamine-modulating properties and BDNF upregulation. Published medical hypothesis work suggests ACTH(4-10) analogs like Semax may be relevant for studying attention and executive function pathways disrupted in ADHD models. The dopaminergic and serotonergic activation Semax produces, combined with BDNF-driven synaptic plasticity, makes it a candidate compound for researchers studying attention, executive function, and catecholamine-related behavioral models.

Semax vs Selank: Choosing the Right Peptide for Your Protocol

Two Neuropeptides, Different Primary Mechanisms

Researchers frequently ask about semax vs selank because both are neuropeptides studied for cognitive and anxiety-related endpoints, and both are often stacked in research protocols. They operate through different primary mechanisms and suit different study designs:

Use Semax when your protocol focuses on cognitive enhancement, neuroplasticity, BDNF-driven effects, or neuroprotection. Use Selank when the primary endpoint is anxiety reduction, GABAergic modulation, or immune-neural interaction. Both are frequently studied together to capture complementary anxiolytic and cognitive effects simultaneously. We stock both.

Semax and Selank: The Research Stack

Why These Two Peptides Are Studied Together

Several keywords in the research community reflect the habit of combining semax and selank in the same protocol. The rationale is mechanistically sound. Semax drives upward on cognitive function through BDNF and dopaminergic activation. Selank moderates anxiety and stress responses through GABAergic and enkephalinergic pathways. Together they cover both the activating and calming sides of neurological regulation, which makes the combination useful for research into stress-cognitive performance relationships, anxiety-learning interactions, and dual-pathway neuropeptide effects.

Both compounds are administered intranasally in published research, which simplifies protocol design when using them together. We carry both in matched batch cycles for researchers running combination studies.

Semax Nasal Spray: Administration in Research

Why Intranasal Administration

The intranasal route is standard for Semax in published research for two reasons. First, the olfactory epithelium provides direct access to the central nervous system, bypassing the blood-brain barrier entirely through olfactory nerve pathways. Second, Semax’s Pro-Gly-Pro modification increases its BBB penetration through conventional routes as well, but intranasal delivery is faster and more reliable for achieving brain concentrations in research models.

Semax is supplied as lyophilized powder, which is reconstituted with bacteriostatic water before intranasal administration in research protocols.

How to Reconstitute Semax for Intranasal Research Use

1. Sanitize the vial stopper with 70% isopropyl alcohol
2. Inject bacteriostatic water slowly against the vial wall. Do not aim at the lyophilized cake directly
3. Allow the cake to dissolve without agitation for 1 to 2 minutes. Semax dissolves readily
4. Gently swirl until fully clear. Do not shake
5. Transfer to a sterile nasal dropper device for intranasal administration in research models
6. Label with reconstitution date and final concentration

Concentration reference:

For 5mg vial:

• 5mg + 0.5mL bacteriostatic water = 10mg/mL
• 5mg + 1mL bacteriostatic water = 5mg/mL
• 5mg + 2.5mL bacteriostatic water = 2mg/mL

For 10mg vial:

• 10mg + 1mL bacteriostatic water = 10mg/mL
• 10mg + 2mL bacteriostatic water = 5mg/mL
• 10mg + 5mL bacteriostatic water = 2mg/mL

Storage Requirements

• Lyophilized powder: 24 months at -20°C, protected from light
• Reconstituted solution: 14 days at 2 to 8°C under sterile conditions. Do not freeze
• Once transferred to a dropper device, use within the stability window and keep refrigerated between uses
• Protect from light at all stages

Semax Dosage: Published Research Protocols

Animal Model Dosing

Researchers searching for semax dosage information find a reasonably well-documented literature base given the compound’s history in Russian pharmacological research:

• Cognitive and nootropic studies: 25 to 100 mcg/kg administered intranasally in rodent models
• Stroke and neuroprotection studies: 50 to 200 mcg/kg administered intranasally, typically over 5 to 10 day protocols
• Anxiety and behavioral studies: 25 to 50 mcg/kg in neonatal and adolescent rodent models
• Cardiovascular studies: Doses administered over 6-day post-infarction protocols in murine models

These figures come from peer-reviewed publications and provide validated frameworks for protocol design. Translation between species requires allometric scaling appropriate to your research model.

Semax Dosage Chart for Common Research Concentrations

We do not provide human dosing recommendations. Semax is not approved for human use and is sold strictly for research purposes.

Semax Side Effects: What Research Models Show

Published Safety Profile

In published animal and limited human research, Semax has shown a relatively clean safety profile compared to other neuropeptides. Commonly noted observations include:

• Mild nasal irritation in intranasal administration models, typical of any intranasally delivered compound
• Transient changes in alertness and arousal at higher doses, consistent with its dopaminergic mechanism
• No significant hormonal disruption, which distinguishes it from ACTH itself

Does Semax Cause Hair Loss?

This question appears frequently in researcher and nootropics communities. Published research does not document hair loss as an observed effect in animal studies. The concern likely originates from anecdotal reports in self-experimentation communities rather than controlled research. No mechanism connecting Semax to hair follicle disruption has been proposed in peer-reviewed literature. Researchers designing protocols do not currently flag hair loss as an expected adverse finding based on available data.

What Is Semax Peptide Used For? Research Summary

Approved Research Applications

Semax is used in laboratory research for:

• Cognitive enhancement and nootropic effect mechanisms through BDNF and monoamine modulation
• Anxiety and stress response through enkephalinase inhibition and monoamine rebalancing
• Neuroprotection in ischemic stroke and brain injury models
• ADHD-related attention and executive function pathway research
• Cardiovascular protection in post-infarction remodeling models
• Immune and vascular gene expression studies
• Comparison and combination protocols with Selank

It is not approved for human therapeutic use and is sold exclusively for in vitro and controlled in vivo research.

Product Specifications

H3: Available Configurations

Semax is available in 5mg and 10mg vials. Select your configuration from the product options above.

Quality Verification

• Purity: 99% minimum (HPLC verified)
• Sequence identity: Mass spectrometry confirmed, MEHFPGP
• Molecular Weight: 854.99 g/mol
• Endotoxin: Less than 0.1 EU/mL
• Sterility: Verified per USP 71
• Form: Lyophilized powder
• Storage: -20°C long-term, 2 to 8°C short-term

Current Batch: #PPF-SMX-0426 Purity: 99.2% Download: HPLC Certificate | MS Report

FAQ

What is semax nasal spray used for in research?

Semax is used intranasally in research models to study cognitive enhancement, neuroprotection, anxiety reduction, stroke recovery, ADHD-related attention mechanisms, and cardiovascular protection after myocardial infarction. Intranasal administration is the standard route in published protocols due to direct access to central nervous system pathways.

What are the benefits of semax peptide in research models?

Published studies show BDNF upregulation, serotonin metabolite elevation up to 180%, improved memory recall and focus, reduced anxiety behavior, enhanced neurological recovery after stroke, and cardioprotection following experimental myocardial infarction.

What is semax vs selank in research contexts?

Semax activates cognitive pathways through BDNF and dopamine/serotonin upregulation. Selank primarily modulates anxiety through GABAergic and enkephalinergic mechanisms. Both are administered intranasally and are frequently studied in combination to capture complementary neurological effects.

What is the semax dosage in animal studies?

Published rodent protocols use 25 to 100 mcg/kg for cognitive studies and 50 to 200 mcg/kg for neuroprotection and stroke models, administered intranasally. All dosing should follow published protocols appropriate to your specific research model and endpoints.

What are semax side effects in research models?

Published animal research reports mild nasal irritation and transient alertness changes at higher doses. No hormonal disruption, hair loss, or significant adverse findings have been documented in controlled research settings.

Does semax cause hair loss?

No peer-reviewed research documents hair loss as an effect of Semax in controlled animal studies. No proposed mechanism connects Semax to hair follicle disruption. The concern originates in self-experimentation communities rather than published research.

What is N-Acetyl Semax Amidate and how does it differ?

N-Acetyl Semax Amidate is a modified form with an acetyl group at the N-terminus and an amide at the C-terminus. These modifications further increase stability and potency compared to standard Semax. Standard Semax as supplied here has the foundational research base and is the version used in most published clinical and animal studies. Contact us regarding N-Acetyl Semax Amidate availability.

Is semax peptide good for ADHD research?

Published medical hypothesis work and mechanistic studies support Semax as a relevant compound for ADHD research based on its dopaminergic activation and BDNF upregulation, both of which are relevant to attention and executive function pathways studied in ADHD models.

Where can I buy semax nasal spray for research?

Pure Peptide Factory stocks research-grade Semax in 5mg and 10mg vials with domestic cold-chain shipping. Orders placed before 2 PM EST ship same-day.

What is the best peptide for anxiety research?

Selank is the more selective choice for anxiety-focused protocols. Semax has documented anxiolytic effects but also strong cognitive and BDNF-driven components that may confound pure anxiety endpoint studies. For combined anxiety and cognitive research, both together provide the broadest coverage. We stock both.

Order Semax for Research

Secure Checkout

• Credit card, cryptocurrency, or wire transfer
• Same-day dispatch for orders placed before 2 PM EST
• Cold-chain packaging with phase-change cooling
• Discreet labeling and full tracking

Institutional Accounts

Net-30 terms and purchase order acceptance available for universities and pharmaceutical companies. Contact us for bulk pricing on 50 vials or more.

Add to cart and get batch-verified Semax delivered to your lab with the documentation your protocol requires.